Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DepoTech withdraws MAA for Savedar for solid tumor indication

Oct. 19, 1998

Melatonin prevents doxorubicin-induced cardiotoxicity in rat model

Oct. 19, 1998

New drug delivery technology soon to enter clinical testing

Oct. 19, 1998

Wayne Hughes Institute develops potent new agent for breast cancer

Oct. 16, 1998

Gene for Rx, Dx of liver cancer available for licensing from RCT

Oct. 16, 1998

Scientists at Cell Therapeutics disclose new signal transduction inhibitors

Oct. 16, 1998

New animal model of bone metastasis developed at AntiCancer

Oct. 16, 1998

Novel anticancer agent from ProScript moves into clinical testing

Oct. 16, 1998

Taxol combination therapy approved in France for NSCLC indication

Oct. 16, 1998

BioNumerik publishes preclinical data on BNP-7787 in cancer journal

Oct. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...